Combined effects methylation of FHIT, RASSF1A and RARβ genes on non-small cell lung cancer in the Chinese population

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 13, 2014, Pages 5233-5237

  Li, Wen ^a   Deng, Jing ^a   Tang, Jian Xin ^a  

^a HUNAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Combined effect; FHIT; Methylation; Non small cell lung cancer; RAR gene; RASSF1A gene

Indexed keywords

ACID ANHYDRIDE HYDROLASE; FRAGILE HISTIDINE TRIAD PROTEIN; RASSF1 PROTEIN, HUMAN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; TUMOR MARKER; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; DNA METHYLATION; GENETICS; HUMAN; LUNG TUMOR; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROMOTER REGION;

ACID ANHYDRIDE HYDROLASES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DNA METHYLATION; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84905395399     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.13.5233     Document Type: Article

References (25)

1. Al-Temaimi RA, Jacob S, Al-Ali W, et al (2013). Reduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer. Histochem Cytochem, 61, 627-38.
2. Bodoor K, Haddad Y, Alkhateeb A, et al (2014). DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients. Asian Pac J Cancer Prev, 15, 75-84.
3. Botana-Rial M, De Chiara L, Valverde D, et al (2012). Prognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma. Cancer Biol Ther, 13, 1436-42 .
4. Chen X, Li P, Yang Z, et al (2013). Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 14, 165-71.
5. Deng YF, Zhang L, Zhang XQ, et al (2012). Methylation of FHIT gene promoter region in DNA from plasma of patients with myelodysplastic syndromes and demethylating effect of decitabine. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 20, 1144-8.
6. Dumitrescu RG (2012). Epigenetic markers of early tumor development. Methods Mol Biol, 863, 3-14.
7. Fiolka R, Zubor P, Janusicova V, et al (2013). Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncol Rep, 30, 2878-86.
8. Fujiwara K, Fujimoto N, Tabata M, et al (2005). Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res, 11, 1219-25.
9. Grote HJ, Schmiemann V, Geddert H, et al (2006). Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Cancer, 108, 129-34.
10. Hesson LB, Cooper WN, Latif F (2007). The role of RASSF1A methylation in cancer. Dis Markers, 23, 73-87.
11. Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.
12. Jeong YJ, Jeong HY, Lee SM, et al (2013). Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients. Oncol Rep, 30, 2270-8.
13. Ki KD, Lee SK, Tong SY, et al (2008). Role of 5'-CpG island hypermethylation of the FHIT gene in cervical carcinoma. J Gynecol Oncol, 19, 117-22.
14. Ko E, Lee BB, Kim Y, Lee EJ, et al (2013). Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer. Clin Cancer Res, 19, 1204-12.
15. Li W, Deng J, Jiang P, et al (2012). Methylation of the RASSF1A and RARβ genes as a candidate biomarker for lung cancer. Exp Ther Med, 3, 1067-71.
16. Liu WJ, Tan XH, Guo BP, et al (2013). Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data. Asian Pac J Cancer Prev, 14, 3719-24.
17. Mengxi D, Qian W, Nan W, et al (2013). Effect of DNA methylation inhibitor on RASSF1A genes expression in non-small cell lung cancer cell line A549 and A549DDP. Cancer Cell Int, 13, 91.
18. Missaoui N, Hmissa S, Dante R, Frappart L, et al (2010). Global DNA methylation in precancerous and cancerous lesions of the uterine cervix. Asian Pac J Cancer Prev, 11, 1741-4.
19. Moison C, Senamaud-Beaufort C, Fourrière L, et al (2013). DNA methylation associated with polycomb repression in retinoic acid receptor β silencing. FASEB J, 27, 1468-78.
20. Neyaz MK, Kumar RS, Hussain S, et al (2008). Effect of aberrant promoter methylation of FHIT and RASSF1A genes on sudceptibility to cervical cancer in a North Indian population, Biomarkers, 13, 597-606.
21. Toyooka S, Suzuki M, Maruyama R, et al (2004). The relationship between aberrant methylation and survival in non-small-cell lung cancers. Br J Cancer, 91, 771-4.
22. Virmani AK, Rathi A, Zochbauer-Muller S, et al (2000). Gazdar AF Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst, 92, 1303-7.
23. Vo LT, Thuan TB, Thu DM, et al (2013). Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer. Asian Pac J Cancer Prev, 14, 7713-8.
24. Zochbauer-Muller S, Minna JD, Gazdar AF (2002). Aberrant DNA methylation in lung cancer: biological and clinical implications. Oncologist, 7, 451-7.
25. Zuo H, Chan AS, Ammer H, et al (2013). Activation of Gaq subunits up-regulates the expression of the tumor suppressor Fhit. Cell Signal, 25, 2440-52.